Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inhibitory synaptic factor family member 2B (INSYN2B)
- Target
- INSYN2B
- Molecular classification
- Other (protein of unknown detailed molecular function; not classified as receptor, enzyme, ion channel, transporter, or transcription factor by current resources)
01
Overview
Inhibitory synaptic factor family member 2B (INSYN2B) is a human protein-coding gene, also known by the aliases C5orf57 and FAM196B. It is predicted to participate in the modulation of inhibitory postsynaptic potentials within neuronal circuits, with localization inferred in postsynaptic density regions. The specific molecular function, biological processes, and clinical relevance remain uncharacterized due to lack of experimental annotation. Current genetic information places INSYN2B on chromosome 5, but no direct links to disease, drug interactions, or recognized biomarker status have been established
- Other names
- INSYN2BC5orf57FAM196BProtein INSYN2BFamily with sequence similarity 196 member BProtein FAM196B
02
Mechanism of action
None known (No mechanisms of action described for drugs targeting INSYN2B, consistent with its non-target status)
03
Biological functions
Possible regulation of inhibitory postsynaptic potentialActivity in postsynaptic densityOther (due to lack of direct experimental evidence, biological functions are inferred and not well-defined)
04
Disease associations
Other (No disease associations currently established; databases do not link INSYN2B to cancer, inflammation, neurodegenerative, or other common therapeutic contexts)
05
Safety considerations
None established (No safety concerns or therapeutic challenges identified in the literature or public genetic databases for INSYN2B)
06
Interacting drugs
None known (No drugs or small molecules reported to interact with INSYN2B as of latest database updates)
07
Biomarkers
None known (Not currently recognized as a biomarker for patient selection or efficacy in any disease)
Beyond the preview
Go deeper on Inhibitory synaptic factor family member 2B (INSYN2B).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inhibitory synaptic factor family member 2B (INSYN2B).